“Radiotracers developments, surge in prevalence of cardiovascular diseases and cancer, increase in investment in modernization of diagnostic imaging centers, and advent of advanced equipment drive the growth of global nuclear medicine equipment market. The oncology segment accounted for more than two-thirds of the total share of the market in 2015.”
The global nuclear medicine equipment market is estimated to reach $2.64 billion by 2022, from $2.01 billion in 2015, registering a CAGR of 3.9% from 2016 to 2022. The report offers a detailed analysis of the key segments including top investment pockets, changing dynamics, market size & estimations, and competitive scenario.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1828
Nuclear medicine equipment including PET/CT and SPECT scans are utilized for collecting radiation from small radioisotopes that reside into the body. This equipment thus helps in carrying out diagnosis of diseases and analyze the treatment response to the patient. The crucial factors driving the growth of the market include advent of advanced equipment, surge in prevalence of cardiovascular diseases and cancer, increase in investment in modernization of diagnostic imaging centers, and radiotracers developments.
The oncology segment is anticipated to maintain its leadership position during the forecast period, owing to the surge in incidence of cancer and rise in awareness regarding early diagnosis. However, the neurology segment is expected to register the highest growth rate as this equipment can be utilized for diagnosis and assessment of the treatment response to different neurological disorders including Alzheimer’s disease, vascular dementia, brain death/injury, stroke & transient ischemic attack, and others.
The hospitals segment accounted for nearly two-fifths of the total market share in 2015, and is estimated to maintain its position during the forecast period. This is due to the growth of the number of patients in hospitals with increase in the occurrence of chronic diseases. Based on region, North America contributed the highest market share in the market in 2015, and is expected maintain its leadership position in the future. This is due to the presence of huge geriatric population, advancements in technology, supportive imbursement policies, and affordability for buying modern and expensive equipment.
The key players analyzed in the report include
- General Electric Company
- Siemens Aktiengesellschaft
- Koninklijke Philips N.V.
- Mediso Medical Imaging Systems, Ltd.
- Digirad Corporation
- Bozlu Holding
- Toshiba Corporation
- Compaa Mexicana de Radiologa CGR
- S.A. de C.V.
- Neusoft Corporation
- SurgicEye GmbH.
They have adopted various strategies including expansion, collaborations, partnership, mergers & acquisitions, and others to gain a strong position and make international presence.
NUCLEAR MEDICINE EQUIPMENT MARKET KEY FINDINGS:
- Hybrid PET segment is projected to grow at the highest rate during the analysis period.
- Argentina nuclear medicine equipment market is estimated to grow at a CAGR of 6.0%.
- Oncology dominated the global nuclear medicine equipment market in 2015.
- U.S. was the largest market in 2015, and is projected to maintain its lead until 2022.
- Hospitals segment is projected to dominate throughout 2022.
Scope of the Report
| Report Attribute | Details |
| Market size available for years | 2014-2022 |
| Base year considered | 2015 |
| Forecast period | 2015-2022 |
| Forecast units | Value (USD) |
| Segments covered | Product Type, Application and End User |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
Related Report
Precision Medicine Market by Technology (Genomics, Transcriptomics and Epigenomics), by Sequencing Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing and Nanopore Sequencing), Product (Consumables, Instruments and Services) Application (Oncology, CNS, Immunology, Respiratory Medicine, Infections, and Other Applications) End User (Diagnostic Tool companies, Pharma & Biotech Companies, Clinical Laboratories, and Healthcare IT/Big Data Companies) – Global Opportunity Analysis and Industry Forecast, 2017-2023
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2311
Nuclear Medicine Market by Type (Diagnostic, Therapeutic), Modality (SPECT, PET, Alpha-emitters, Beta-emitters, Brachytherapy), Application (Oncology, Cardiology, Neurology, Thyroid), Procedures (Central Nervous System, Endocrine, Skeletal, Gastrointestinal, Genito-urinary, Pulmonary) and End User (Hospitals and diagnostic centers, Research institutes) – Global Opportunity Analysis and Industry Forecast, 2014 – 2022
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1131
Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Read More @ https://www.alliedmarketresearch.com/press-release/nuclear-medicine-equipment-market.html